Steve Lopez, a columnist for the Los Angeles Times, participated in biomonitoring tests with ten other people and writes about the troubling results in his June 8 column, "We've Got Really Bad Chemistry". As California considers a bill for a state-wide biomonitoring research program, this test case bolsters the claims that biomonitoring can become a useful tool for protecting human health.